-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Welcoming three new Deputy Editors-in-Chief at PLOS Computational Biology in Work In Progress
- A New Association Wants YOU! Calling all Supporters of Citizen Science! in Work In Progress
- Help stop fat bullying in Work In Progress
- Childhood obesity drops 40% in the last decade. Or not really, but who's checking? in Work In Progress
- 3 Ways to Bridge the Behaviour-Intention Gap in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Category Archives: ethics
The Battle Over Generic Drugs in India (and elsewhere)
Category: cancer, drug patents, ethics, generic drugs, Healthcare disparities
Tagged antiretroviral drugs, Cipla, CML, erlotinib, generic drugs, Gleevec, HIV/AIDS, imatinib, India, lung cancer, Novartis, patents, Roche, Tarceva, TRIPS
2 Comments
Let the Death Panel Accusations Fly!
Category: Clinical Trials, Drug Development, ethics
Tagged Avastin, bevacizumab, breast cancer, drug approvals, drug development, FDA, Genentech, insurance coverage, National Comprehensive Cancer Network, ODAC
Comments Off
The Avastin Saga
Category: cancer, drug cost, ethics
Tagged Avastin, breast cancer, cost:benefit ratio, FDA, insurance, Medicaid, medicare, NCCN, overall survival, progression-free survival
9 Comments
Can Data Exclusivity Lead to Immortality?
Category: drug cost, ethics, healthcare reform, Legislation
Tagged biologics, data exclusivity, generic drugs, legislation
Comments Off
Welcome to a Work in Progress
Category: drug cost, ethics, Housekeeping
Tagged boceprevir, drug costs, hepatitis C, insurance, medicare, telaprevir
10 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.